12-10-2022 14:00 via wallstreet-online.de

Halberd Progresses from Eliminating Top Brain Disease Antigens from CSF To Eradication of Interleukin-6 From Human Blood Serum

Excess IL-6 is associated with inflammation in rheumatoid arthritis, MS, some cancers and neurodegenerative diseases.JACKSON CENTER, PA / ACCESSWIRE / October 12, 2022 / Halberd Corporation (OTC PINK:HALB) demonstrated the removal of Interleukin-6 …
Weiterlesen »